BridgeBio LLC
NEWS
The transaction between BridgeBio and Eidos is expected to close in the first quarter of 2021.
Biopharma and life sciences companies bolster their executive teams and board with these Movers & Shakers.
Check out this article for the impacts that Biotech Bay companies are experiencing due to COVID-19.
Biopharma and life sciences strengthen their executive leadership teams and boards with this week’s Movers & Shakers.
With the J.P. Morgan Healthcare Conference in full swing, companies did not waste time in announcing deals and providing updates to their pipelines. BioSpace takes a look at some of the announcements made on day one of the annual conference in the Bay Area.
The first full business week of the new year began with plenty of clinical trial news. Here’s a look.
Here’s a look at some of the biggest U.S. Nasdaq-based initial public offerings in 2019 and some of the more intriguing ones.
It was, as usual, a pretty busy week in clinical trial news. Here’s a look.
Preclinical data shows SHP2 inhibitor enhances activity of osimertinib in EGFR-driven tumor xenografts
JOBS
IN THE PRESS